Sphere-forming cells display stem cell-like characteristics and increased xCT expression in a canine hepatocellular carcinoma cell line. (October 2021)

• Record Type: Journal Article
• Authors: Itoh, Harumichi; Tani, Kenji; Sunahara, Hiroshi; Nakaichi, Munekazu; Iseri, Toshie; Horikirizono, Hiro; Itamoto, Kazuhito
• Is Part Of: Research in veterinary science. Volume 139(2021)
• Page Start: 25
• Page End: 31
• Publication Date: 2021-10
• Subjects: Hepatocellular carcinoma -- Cancer stem cell -- Sphere-forming cell -- xCT; Veterinary medicine -- Periodicals; Veterinary Medicine -- Periodicals; Médecine vétérinaire -- Périodiques; Médecine vétérinaire -- Recherche -- Périodiques; Diergeneeskunde; 636.089
• DOI: 10.1016/j.rvsc.2021.06.013
• Languages: English
• ISSNs: 0034-5288

Abstract

Abstract: Hepatocellular carcinoma (HCC) is the most common type of canine primary liver tumor; however, most chemotherapies against HCC are ineffective due to resistance to anticancer agents. Sphere-forming cells are considered to act as cancer stem cells for various types of solid tumors and have been established for many canine tumor cell lines, yet no studies have reported sphere-forming cells for canine HCC. In this study, we established sphere-forming cells from a canine HCC cell line (AZACH). These cells displayed increased stem cell marker mRNA expression (Nanog, Sox2, c-Myc, and Klf4), aldehyde dehydrogenase activity, and chemoresistance against mitoxantrone, gemcitabine, and doxorubicin. In addition, sphere-forming cells exhibited higher xCT expression and lower intracellular reactive oxygen species levels than adherent cells. Treatment with sulfasalazine, a xCT-specific inhibitor, reduced sphere formation efficiency. Together, these results indicate that sphere-forming cells derived from a canine HCC cell line have similar characteristics to cancer stem cells and that their increased xCT expression and associated resistance to oxidative stress contribute toward sphere formation. Highlights: We established sphere-forming cells (SFCs) from a canine HCC cell line (AZACH). SFCs had increased stem cell marker expression and aldehyde dehydrogenase activity. SFCs displayed increased chemoresistance and xCT expression. Sulfasalazine reduced sphere formation efficiency and intracellular ROS levels. SFCs from canine HCC cell lines have similar characteristics to cancer stem cells.